Dosing
How muchdo I take?
Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.
Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.
Starting Dose
250 mcg
Frequency
Once daily
Duration
1-2 weeks
A common starting amount in research practice, often injected near the injured area. BPC-157 has no human dose-finding trials, so doses come from animal studies and documented practice [1][2].
Standard Dose
250-500 mcg
Twice daily
4-6 weeks
Commonly used range for tissue and tendon recovery in research practice [1][3].
Advanced Dose
500 mcg
6-8 weeks
Upper end used in practice for more demanding acute injuries [1][3].
Timing
Best time to take
Administer at a consistent time each day. Consistency matters more than the specific time of day.
With food?
Food timing does not significantly affect absorption for injectable peptides.
If stacking
If combining BPC-157 with other peptides, space administrations by 15-30 minutes. Consult your healthcare provider before combining with prescription medications.
Adjusting Your Dose
Increase if
+Current dose is well-tolerated for 2+ weeks
+Desired effects not yet noticeable
+Healthcare provider recommends dose increase
Decrease if
-Side effects become bothersome or persistent
-Desired effects achieved at lower dose
-Healthcare provider recommends reduction
Signs of right dose
✓Noticeable improvement in target symptoms
✓Good tolerance with minimal side effects
✓Consistent positive response between doses
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
The weight is on the label
Select Weight
Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)
Administration
How do Iuse it?
Reconstitution
What you need
•Bacteriostatic water (BAC water)
•Insulin syringes (29-31 gauge)
•Alcohol swabs
•Sharps container
Example
If using a standard vial, add bacteriostatic water to achieve your desired concentration. For example, adding 2mL of BAC water to a vial allows precise dosing with an insulin syringe.
Draw up the appropriate volume based on your reconstitution ratio. Consult dosing charts for exact volumes corresponding to 250-500 mcg doses.
Injection
Route
Subcutaneous injection (into the fatty tissue just under the skin)
Best sites
•Lower abdomen (2 inches from navel)
•Outer thigh (middle third)
•Back of upper arm
Technique
1.Wash hands and prepare clean workspace
2.Clean injection site with alcohol swab
3.Draw correct dose into insulin syringe
4.Pinch skin and insert needle at 45-90 degree angle
5.Inject slowly, withdraw needle
6.Apply gentle pressure—do not rub
7.Dispose of syringe in sharps container
Storage
Before reconstitution
Store in refrigerator at 36-46°F (2-8°C). Keep in original packaging to protect from light. Do not freeze.
After reconstitution
Store reconstituted solution in refrigerator at 36-46°F (2-8°C). Use within 30 days. Do not freeze reconstituted solution.
Signs of degradation
Solution appears cloudy or discolored
Visible particles or precipitates in solution
Solution has changed color from original appearance
Vial has been exposed to temperatures above 77°F (25°C) for extended periods
Sample Daily Schedule
Morning (8:00 AM)
250mcg injection
Site: Near injury or abdomen
Administer via subcutaneous injection in the morning for consistency. Inject near the site of injury for optimal localized healing effects, or in the abdomen for systemic benefits.
Evening (8:00 PM)
Site: Rotate from morning
Duration: Continue for 4-6 weeks. Then: 2-4 week break before restarting if needed.
Safety
Is itsafe?
Safety Profile
BPC-157 is a gastric pentadecapeptide with strong preclinical evidence from extensive animal studies spanning over 25 years of research. Critical limitation: BPC-157 has NOT completed Phase 3 human clinical trials. No FDA approval exists. Safety data comes primarily from rat and mouse studies, with only limited Phase 1-2 human data. Animal studies show no toxicity at therapeutic doses, but human data is insufficient for regulatory approval. The peptide is unregulated, and no standardized manufacturing or quality control requirements exist for research compounds. Individual responses may vary significantly, and serious medical supervision is essential before use, particularly if you have gastrointestinal conditions, take medications, or have pre-existing medical conditions.
BPC-157's evidence base is categorized as 'Strong preclinical' based on extensive rat models demonstrating accelerated healing across multiple tissue types including tendon, ligament, muscle, and GI mucosa. However, no completed Phase 3 human clinical trials exist. Published human data is limited to a small number of early-phase studies and case reports. Manufacturing quality varies significantly between suppliers as the compound is not regulated by the FDA.
Common Side Effects
Experienced by some users
Injection site redness
Usually resolves in 30-60 minutes
Management: Rotate sites, ice if needed
Mild nausea
Typically only first few doses
Management: Take with food, reduce dose temporarily
Dizziness
Rare, usually with higher doses
Management: Reduce dose, stay hydrated
Less Common
•Headache
•Fatigue
•Hot/cold sensations
These typically resolve with continued use or dose adjustment.
Stop and Seek Help If
×If you experience severe or persistent injection site reactions or signs of infection
×If you develop signs of an allergic reaction such as difficulty breathing, swelling, or severe rash
×If healing progress plateaus after 6+ weeks of continuous use, indicating need for reassessment or alternative approaches
Always consult with a healthcare provider before discontinuing BPC-157, especially if used for active injury recovery. Do not stop abruptly without medical guidance as this may impact healing outcomes.
Interactions
With other peptides
✓TB-500
✓GHK-Cu
✓CJC-1295 + Ipamorelin
With medications
!Blood Thinners - Blood Thinners (Warfarin
!etc.) - etc.)
!NSAIDs - NSAIDs (Ibuprofen
With supplements
✓Vitamin D3 - Generally safe and may support overall health
✓Magnesium - Generally safe and may enhance peptide absorption
Want the Full Picture?
View the complete BPC-157 research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.